Click for best price
Premenstrual Syndrome Treatment Market Size, Share 2024
The global Premenstrual Syndrome Treatment market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Premenstrual Syndrome Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Premenstrual Syndrome Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Premenstrual Syndrome Treatment market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Medication Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Premenstrual Syndrome Treatment include AbbVie, AstraZeneca, BASF Corporation, Bayer, Eli Lilly And Company, GlaxoSmithKline, Pfizer and Shionogi, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Premenstrual syndrome or PMS is a group of physical and emotional symptoms many women may have in the days before their period starts. Symptoms usually stop once the period starts. It?s thought to be related to the changing hormone levels of the menstrual cycle.Lifestyle changes and sometimes medicine are used to treat PMS.
This report aims to provide a comprehensive presentation of the global market for Premenstrual Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Premenstrual Syndrome Treatment. This report contains market size and forecasts of Premenstrual Syndrome Treatment in global, including the following market information:
Global Premenstrual Syndrome Treatment Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We has surveyed the Premenstrual Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Premenstrual Syndrome Treatment Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Premenstrual Syndrome Treatment Market Segment Percentages, by Type, 2023 (%)
- Medication
- Dietary Treatment
- Emotional Treatment
- Hormone Therapy
- Others
Global Premenstrual Syndrome Treatment Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Premenstrual Syndrome Treatment Market Segment Percentages, by Application, 2023 (%)
- Younger than 20 Years
- 20-40 Years Old Adults
Global Premenstrual Syndrome Treatment Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Premenstrual Syndrome Treatment Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Premenstrual Syndrome Treatment revenues in global market, 2019-2024 (estimated), ($ millions)
- Key companies Premenstrual Syndrome Treatment revenues share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- AbbVie
- AstraZeneca
- BASF Corporation
- Bayer
- Eli Lilly And Company
- GlaxoSmithKline
- Pfizer
- Shionogi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Premenstrual Syndrome Treatment, market overview.
Chapter 2: Global Premenstrual Syndrome Treatment market size in revenue.
Chapter 3: Detailed analysis of Premenstrual Syndrome Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Premenstrual Syndrome Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Premenstrual Syndrome Treatment Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Premenstrual Syndrome Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Premenstrual Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Premenstrual Syndrome Treatment Overall Market Size
2.1 Global Premenstrual Syndrome Treatment Market Size: 2023 VS 2030
2.2 Global Premenstrual Syndrome Treatment Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Premenstrual Syndrome Treatment Players in Global Market
3.2 Top Global Premenstrual Syndrome Treatment Companies Ranked by Revenue
3.3 Global Premenstrual Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Premenstrual Syndrome Treatment Companies in Global Market, by Revenue in 2023
3.5 Global Companies Premenstrual Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Premenstrual Syndrome Treatment Players in Global Market
3.6.1 List of Global Tier 1 Premenstrual Syndrome Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Premenstrual Syndrome Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Premenstrual Syndrome Treatment Market Size Markets, 2023 & 2030
4.1.2 Medication
4.1.3 Dietary Treatment
4.1.4 Emotional Treatment
4.1.5 Hormone Therapy
4.1.6 Others
4.2 By Type - Global Premenstrual Syndrome Treatment Revenue & Forecasts
4.2.1 By Type - Global Premenstrual Syndrome Treatment Revenue, 2019-2024
4.2.2 By Type - Global Premenstrual Syndrome Treatment Revenue, 2025-2030
4.2.3 By Type - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Premenstrual Syndrome Treatment Market Size, 2023 & 2030
5.1.2 Younger than 20 Years
5.1.3 20-40 Years Old Adults
5.2 By Application - Global Premenstrual Syndrome Treatment Revenue & Forecasts
5.2.1 By Application - Global Premenstrual Syndrome Treatment Revenue, 2019-2024
5.2.2 By Application - Global Premenstrual Syndrome Treatment Revenue, 2025-2030
5.2.3 By Application - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Premenstrual Syndrome Treatment Market Size, 2023 & 2030
6.2 By Region - Global Premenstrual Syndrome Treatment Revenue & Forecasts
6.2.1 By Region - Global Premenstrual Syndrome Treatment Revenue, 2019-2024
6.2.2 By Region - Global Premenstrual Syndrome Treatment Revenue, 2025-2030
6.2.3 By Region - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Premenstrual Syndrome Treatment Revenue, 2019-2030
6.3.2 US Premenstrual Syndrome Treatment Market Size, 2019-2030
6.3.3 Canada Premenstrual Syndrome Treatment Market Size, 2019-2030
6.3.4 Mexico Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Premenstrual Syndrome Treatment Revenue, 2019-2030
6.4.2 Germany Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.3 France Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.4 U.K. Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.5 Italy Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.6 Russia Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.7 Nordic Countries Premenstrual Syndrome Treatment Market Size, 2019-2030
6.4.8 Benelux Premenstrual Syndrome Treatment Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Premenstrual Syndrome Treatment Revenue, 2019-2030
6.5.2 China Premenstrual Syndrome Treatment Market Size, 2019-2030
6.5.3 Japan Premenstrual Syndrome Treatment Market Size, 2019-2030
6.5.4 South Korea Premenstrual Syndrome Treatment Market Size, 2019-2030
6.5.5 Southeast Asia Premenstrual Syndrome Treatment Market Size, 2019-2030
6.5.6 India Premenstrual Syndrome Treatment Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Premenstrual Syndrome Treatment Revenue, 2019-2030
6.6.2 Brazil Premenstrual Syndrome Treatment Market Size, 2019-2030
6.6.3 Argentina Premenstrual Syndrome Treatment Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Premenstrual Syndrome Treatment Revenue, 2019-2030
6.7.2 Turkey Premenstrual Syndrome Treatment Market Size, 2019-2030
6.7.3 Israel Premenstrual Syndrome Treatment Market Size, 2019-2030
6.7.4 Saudi Arabia Premenstrual Syndrome Treatment Market Size, 2019-2030
6.7.5 UAE Premenstrual Syndrome Treatment Market Size, 2019-2030
7 Premenstrual Syndrome Treatment Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Premenstrual Syndrome Treatment Major Product Offerings
7.1.4 AbbVie Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Premenstrual Syndrome Treatment Major Product Offerings
7.2.4 AstraZeneca Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 BASF Corporation
7.3.1 BASF Corporation Company Summary
7.3.2 BASF Corporation Business Overview
7.3.3 BASF Corporation Premenstrual Syndrome Treatment Major Product Offerings
7.3.4 BASF Corporation Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.3.5 BASF Corporation Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Premenstrual Syndrome Treatment Major Product Offerings
7.4.4 Bayer Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.4.5 Bayer Key News & Latest Developments
7.5 Eli Lilly And Company
7.5.1 Eli Lilly And Company Company Summary
7.5.2 Eli Lilly And Company Business Overview
7.5.3 Eli Lilly And Company Premenstrual Syndrome Treatment Major Product Offerings
7.5.4 Eli Lilly And Company Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.5.5 Eli Lilly And Company Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Premenstrual Syndrome Treatment Major Product Offerings
7.6.4 GlaxoSmithKline Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Premenstrual Syndrome Treatment Major Product Offerings
7.7.4 Pfizer Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.7.5 Pfizer Key News & Latest Developments
7.8 Shionogi
7.8.1 Shionogi Company Summary
7.8.2 Shionogi Business Overview
7.8.3 Shionogi Premenstrual Syndrome Treatment Major Product Offerings
7.8.4 Shionogi Premenstrual Syndrome Treatment Revenue in Global Market (2019-2024)
7.8.5 Shionogi Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Premenstrual Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Premenstrual Syndrome Treatment Market Drivers in Global Market
Table 3. Premenstrual Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Premenstrual Syndrome Treatment in Global Market
Table 5. Top Premenstrual Syndrome Treatment Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Premenstrual Syndrome Treatment Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Premenstrual Syndrome Treatment Revenue Share by Companies, 2019-2024
Table 8. Global Companies Premenstrual Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Premenstrual Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Premenstrual Syndrome Treatment Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Premenstrual Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Premenstrual Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Premenstrual Syndrome Treatment Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Premenstrual Syndrome Treatment Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Premenstrual Syndrome Treatment Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Premenstrual Syndrome Treatment Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Premenstrual Syndrome Treatment Product Offerings
Table 32. AbbVie Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Premenstrual Syndrome Treatment Product Offerings
Table 36. AstraZeneca Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. BASF Corporation Company Summary
Table 39. BASF Corporation Premenstrual Syndrome Treatment Product Offerings
Table 40. BASF Corporation Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 41. BASF Corporation Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Premenstrual Syndrome Treatment Product Offerings
Table 44. Bayer Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 45. Bayer Key News & Latest Developments
Table 46. Eli Lilly And Company Company Summary
Table 47. Eli Lilly And Company Premenstrual Syndrome Treatment Product Offerings
Table 48. Eli Lilly And Company Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 49. Eli Lilly And Company Key News & Latest Developments
Table 50. GlaxoSmithKline Company Summary
Table 51. GlaxoSmithKline Premenstrual Syndrome Treatment Product Offerings
Table 52. GlaxoSmithKline Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 53. GlaxoSmithKline Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Premenstrual Syndrome Treatment Product Offerings
Table 56. Pfizer Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 57. Pfizer Key News & Latest Developments
Table 58. Shionogi Company Summary
Table 59. Shionogi Premenstrual Syndrome Treatment Product Offerings
Table 60. Shionogi Premenstrual Syndrome Treatment Revenue (US$, Mn) & (2019-2024)
Table 61. Shionogi Key News & Latest Developments
List of Figures
Figure 1. Premenstrual Syndrome Treatment Segment by Type in 2023
Figure 2. Premenstrual Syndrome Treatment Segment by Application in 2023
Figure 3. Global Premenstrual Syndrome Treatment Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Premenstrual Syndrome Treatment Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Premenstrual Syndrome Treatment Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Premenstrual Syndrome Treatment Revenue in 2023
Figure 8. By Type - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 9. By Application - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 10. By Type - Global Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 12. By Application - Global Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 14. By Region - Global Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 15. By Country - North America Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 16. US Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 20. Germany Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 21. France Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 28. China Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 32. India Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 34. Brazil Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Premenstrual Syndrome Treatment Revenue Market Share, 2019-2030
Figure 37. Turkey Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Premenstrual Syndrome Treatment Revenue, (US$, Mn), 2019-2030
Figure 41. AbbVie Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. AstraZeneca Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. BASF Corporation Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Bayer Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Eli Lilly And Company Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. GlaxoSmithKline Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Pfizer Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Shionogi Premenstrual Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
